A series of anthraquinone LSD1 inhibitors, such as 5ac and 6x, have also shown significant inhibitory activity against LSD1 and can inhibit the stemness and migration of GC cells and enhance the immune response [146]. This evidence concerns the gene KDM1A and gastric cancer.